REQUEST A DEMO
Total
USD $0.00
Search more companies

Stada Pharm Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: All Other Specialty Food Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Warehousing and Storage | Data Processing, Hosting, and Related Services | Advertising Agencies
Full name: Stada Pharm Sp. z o.o. Profile Updated: October 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Walmark, a.s., a.s. is a consumer healthcare company. The company operates in nine EU countries and sells products in over 40 countries. Walmark, a.s. manufactures a range of consumer health brands, including vitamins, minerals, children's, women's and men's health, joint care, digestive and intestinal, and cough and cold products. Their key brands include Biopron, Martian, Urinal, Proenzi, Prostenal, Beliema, and Sinulan. Walmark, a.s. aims to be a leader in brand free-sale healthcare products and generic medicines in Europe.

Headquarters
Ul. Krakowiakow 44
Warsaw; Mazowieckie; Postal Code: 02-255

Contact Details: Purchase the Stada Pharm Sp. z o.o. report to view the information.

Website: http://www.walmark.eu

Basic Information
Total Employees:
Purchase the Stada Pharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Stada Pharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Stada Pharm Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Stada Pharm Sp. z o.o. report to view the information.
Incorporation Date:
November 29, 2001
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Stada Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
7.47%
Total operating revenue
7.5%
Operating profit (EBIT)
59.23%
EBITDA
70.87%
Net Profit (Loss) for the Period
-97.56%
Total assets
-12.22%
Total equity
1.85%
Operating Profit Margin (ROS)
0.85%
Net Profit Margin
-2.14%
Return on Equity (ROE)
-74.06%
Quick Ratio
-0.24%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?